4 months ago
1
The Indian Institute of Technology Madras (IIT Madras) has released a genome database covering paediatric leukaemia, colorectal and pancreatic cancers. The Bharat Cancer Genome Atlas (BCGA) has been made publically accessible to researchers and clinicians successful India and overseas astatine bcga.iitm.ac.in.
Indian Council of Medical Research study shows that 1 successful 9 Indians is apt to make cancer, with astir 2.5 cardinal radical presently surviving with the illness and incidence rising by 12.8% annually since 2022. Despite this, patients successful India are under-represented successful planetary crab genome studies. To span this gap, IIT Madras had launched the Indian Cancer Genome Programme successful 2020, completing full genome sequencing of diligent samples collected nationwide, with main enactment from Hyundai Motor India’s Hyundai Hope for Cancer initiative, including ₹56 crore successful backing and an further ₹3 crore to enactment attraction for economically weaker families.
The research, led by IIT Madras’ Centre of Excellence connected Cancer Genomics and Molecular Therapeutics, progressive collaborations with Karkinos Healthcare, Mumbai, and aggregate Chennai hospitals. Alongside BCGA, the institute besides launched the Bharat Cancer Genome Grid (BCG2), a clinician-centric level to integrate genomic information into regular oncology practice.
The initiative, supported by the Department of Science and Technology and the National Center for Precision Medicine successful Cancer, besides includes screening camps, technician training, and mobile healthcare outreach.
